Forest Namenda Clears FDA; Alzheimer Drug Shipments To Begin In December
Executive Summary
Forest is planning a slow roll-out of Namenda (memantine) after a faster-than-expected approval of the Alzheimer's agent
You may also be interested in...
Nektar Branches Out In Pain, Hails Next Generation Of Analgesics
At R&D event, company signals shift of Phase III for lead pain drug NKTR-181 to mid-2014 from earlier in the year. Nektar also featured crop of new drugs targeted at different molecular pathways, including NKTR-192, a partial agonist for acute pain, and a new kind of sodium channel blocker called NKTR-171 for neuropathy.
Reminyl Name Change Gives J&J Fresh Message For Galantamine ER Launch
Janssen's name change for its Reminyl Alzheimer's products gives the company a fresh platform for promoting the galantamine extended-release formulation approved by FDA Dec. 22
Reminyl Name Change Gives J&J Fresh Message For Galantamine ER Launch
Janssen's name change for its Reminyl Alzheimer's products gives the company a fresh platform for promoting the galantamine extended-release formulation approved by FDA Dec. 22